Jove
Visualize
お問い合わせ
このページは機械翻訳されています。他のページは英語で表示される場合があります。View in English
  1. ホーム
  3. 研究分野
  5. 生物医学と臨床科学
  7. 心血管医学と血液学
  9. 心臓病 (心血管疾患を含む)
  11. 低用量のアセチルコリンで冠動脈を起こさせる検査で陽性だった患者の臨床的特徴と結果
  1. ホーム
  3. 研究分野
  5. 生物医学と臨床科学
  7. 心血管医学と血液学
  9. 心臓病 (心血管疾患を含む)
  11. 低用量のアセチルコリンで冠動脈を起こさせる検査で陽性だった患者の臨床的特徴と結果

関連する実験動画

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
06:39

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

Published on: August 18, 2016

15.9K

低用量のアセチルコリンで冠動脈を起こさせる検査で陽性だった患者の臨床的特徴と結果

Hiroki Kuji1,2, Yuichi Saito1, Shota Kuranaga3

  • 1Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Japan.

Internal medicine (Tokyo, Japan)
|September 3, 2025

PubMed で要約を見る

まとめ
この要約は機械生成です。

冠動脈内アセチルコリン (ACh) 挑発検査は冠動脈縮性胸痛 (CSA) を診断する. 低用量での陽性反応は,CSA患者における高用量反応と比較して異なるメカニズムとアウトカムを示します.

科学分野:

  • 心臓病科
  • 診断検査
  • 血管医学

背景:

  • 冠動脈アセチルコリン (ACh) 挑発検査は冠動脈縮性心痛 (CSA) の診断のための標準的な侵襲的方法である.
  • 現行のガイドラインでは AChの投与量を増やすことを推奨しているが,低用量での陽性反応の臨床的意義は不明である.

研究 の 目的:

  • CSAの診断のための冠内ACh誘発試験における低用量対高用量の陽性結果の臨床的関連性とアウトカムを調査する.
  • 低用量と高用量で陽性なACh検査結果を持つ患者の間での処置内有害事象と長期的な臨床結果を比較する.

主な方法:

  • 冠動脈内ACH誘発検査を受けたCSAの疑いのある636人の患者の遡及的分析.
  • ACh検査で陽性になった患者は"低用量陽性" (初期用量で陽性) と"高用量陽性" (高用量が必要) と分類された.
  • 2つのポジティブなグループ間のベースラインの特徴,手続きのイベント,および長期的な結果の比較.

主要な成果:

  • 636人の患者のうち,4. 1%が低用量陽性であり, 47. 8%が高用量陽性であった.
  • 低用量陽性群は,高用量陽性群と比較して,試験中にSTセグメントの上昇とフォローアップ中に不安定な胸痛の発生率が高かった.
  • 低用量と高用量陽性群では,発生頻度が異なっていたものの,全体的な長期臨床結果が類似していた.
キーワード:
アセチルコリン誘発結果血管パスティック・アンギナ

さらに関連する動画

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

1.4K
Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

3.7K

関連する実験動画

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
06:39

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

Published on: August 18, 2016

15.9K
Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

1.4K
Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

3.7K

関連する概念動画

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.3K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.3K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

825
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
825
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

1.2K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
1.2K
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

377
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
377
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

869
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
869
Direct-Acting Cholinergic Agonists: Pharmacokinetics01:31

Direct-Acting Cholinergic Agonists: Pharmacokinetics

1.3K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.3K
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

結論:

  • ACh検査によるCSA診断の約10%は低用量で発生し,ユニークな特性を有する潜在的サブグループを示唆しています.
  • ACh検査における用量依存の反応は,CSAにおける異なる病理生理学的メカニズムを反映している可能性があります.
  • 特定のメカニズムを明らかにし,低用量CSA陽性患者の管理戦略を洗練するために,さらなる研究が必要である.